Technology ID

Derivation of a >25 million-year-old Adeno-associated Virus Coat Protein Sequence for Gene Transfer Studies

Lead Inventor
Smith, Richard (NHLBI)
Kotin, Robert (Carbon Biosciences)
Hallwirth, Claus (Children's Medical Research Institute)
Alexander, Ian (Children's Medical Research Institute)
Development Stages
Pre-Clinical (in vitro)
Lead IC

This technology includes a novel capsid protein for recombinant adeno-associated virus (AAV)-mediated gene transfer evaluation. We have identified a "fossilized" endogenous AAV sequence element (referred to as mAAV-EVE) within the germline of an ancient lineage of Australian marsupials and have cloned and sequenced mAAV-EVE orthologs from at least fifteen lineage-specific taxa. Using computational analysis of mAAV-EVE sequence alignments, we have inferred the coat protein sequence of a >25-million-year-old adeno-associated virus which circulated among host species sometime during the Eocene-Oligocene transition. This novel AAV coat protein sequence may provide the basis for recombinant AAV vectors with unique biological properties. Moreover, the method of derivation of the ancient marsupial AAV coat protein sequence may be used for any endogenous AAV sequences occurring within related taxa in sufficient number.

Commercial Applications
Sequence provides a novel capsid protein for recombinant AAV-mediated gene transfer evaluation.

Competitive Advantages
  • Novel AAV coat proteins may confer distinct, advantageous tissue tropisms and/or antigenic properties relative to a specific therapeutic application.
  • As a method, AAV "fossil" mining has the advantage of identifying coat protein variants with a higher probability of biological activity than screening methods relying on random mutagenesis of existing AAV serotypes (such as domain shuffling).
Licensing Contact: